Abstract

Multivitamins, multi-minerals, hematinics, and dietary supplements (MMHDSs) are commonly prescribed to hemodialysis (HD) patients to mitigate the risk of nutrient deficiencies. This cross-sectional, multi-centric study analyzes MMHDS prescribing patterns among HD patients. Patient demographics, medical history, and dialysis-related data were collected. Findings reveal a high prevalence of MMHDS prescriptions, with diverse supplement types, including water-soluble vitamins and essential minerals. Prescription trends were influenced by factors such as patient age, comorbidities, and dialysis duration.

The study highlights variations in MMHDS prescribing practices across different centers, emphasizing the need for personalized dietary therapy. Supplements are commonly prescribed to address nutrient deficiencies, manage chronic kidney disease complications, and improve overall well-being. The findings of the study are crucial for nephrologists, clinical pharmacists, and dietitians in optimizing patient care and minimizing risks.

Understanding MMHDS prescription trends enables healthcare providers to tailor interventions and enhance treatment outcomes. The study underscores the importance of evidence-based guidelines to ensure safe and effective supplement use in HD patients. Future research should explore the long-term impact of these prescribing patterns on health outcomes, dietary balance, and quality of life, ultimately improving patient care and well-being.

Key words: Hemodialysis, multivitamins, multi-minerals, dietary supplements, prescribing patterns, renal dysfunction, South Karnataka, India.